Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference

Core Viewpoint - Compass Therapeutics, Inc. is set to present at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026, highlighting its focus on developing proprietary antibody-based therapeutics for oncology [1]. Presentation Details - The presentation will take place on January 14, 2026, at 7:30 AM PT, and will be available via webcast [2]. - The presentation will be archived on Compass' Events page for future access [2]. - Investors can schedule one-on-one meetings with Compass on the same day by contacting their J.P. Morgan representative [2]. Investor Meetings - Compass will also host investor meetings during the LifeSci Partners Corporate Access Event on January 12 and 13, 2026, in San Francisco, CA [3]. - Interested investors should reach out to their LifeSci representative to arrange a meeting [3]. Company Overview - Compass Therapeutics is a clinical-stage biopharmaceutical company focused on oncology, developing proprietary antibody-based therapeutics to address multiple human diseases [4]. - The company emphasizes the interplay between angiogenesis, the immune system, and tumor growth, aiming to create a robust pipeline of novel product candidates [4]. - Its product candidates target critical biological pathways necessary for effective anti-tumor responses, including angiogenesis modulation and immune response activation [4]. - Founded in 2014, Compass Therapeutics is headquartered in Boston, Massachusetts [4].